Maternal periodontitis and prematurity. Part I: Obstetric outcome of prematurity and growth restriction

S Offenbacher1, S Lieff, K A Boggess

  • 1Center for Oral and Systemic Diseases, Departments of Periodontology and Dental Ecology, University of North Carolina at Chapel Hill, School of Dentistry, Chapel Hill, NC, USA.

Annals of Periodontology
|March 13, 2002
PubMed

Insights

Maternal periodontal disease, including its progression during pregnancy, significantly increases the risk of preterm birth and low birth weight. Addressing oral health in pregnant women may reduce adverse pregnancy outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Periodontology
  • Public Health

Background:

  • Periodontal disease is a common oral condition.
  • Its association with adverse pregnancy outcomes like preterm birth and low birth weight is increasingly recognized.
  • The Oral Conditions and Pregnancy (OCAP) study investigates this link.

Purpose of the Study:

  • To determine if maternal periodontal disease contributes to prematurity and growth restriction.
  • To assess the impact of periodontal disease status and progression during pregnancy on obstetric risk factors.

Main Methods:

  • A 5-year prospective study of pregnant women (OCAP).
  • Full-mouth periodontal examinations at enrollment (before 26 weeks gestation) and postpartum.
  • Analysis of associations between periodontal disease (health, mild, moderate-severe) and pregnancy outcomes (preterm birth, birth weight), adjusting for covariates.

Main Results:

  • Maternal periodontal disease and its progression are significantly associated with higher rates of preterm birth and low birth weight (<2,500g).
  • Prevalence of preterm birth increased with periodontal disease severity: 1.1% (healthy), 3.5% (mild), 11.1% (moderate-severe).
  • Incidence/progression of periodontal disease correlated with smaller birth weight for gestational age.

Conclusions:

  • Maternal periodontal disease and its progression are significant contributors to obstetric risks.
  • These findings highlight periodontal disease as a potentially new, modifiable risk factor for preterm birth and fetal growth restriction.
  • Further consideration of oral health interventions in pregnancy is warranted.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...